Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.600
+0.040 (2.56%)
Sep 15, 2025, 4:00 PM EDT - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $453.87 million as of September 16, 2025. Its market cap has decreased by -44.00% in one year.
Market Cap
453.87M
Enterprise Value
116.55M
1-Year Change
-44.00%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $453.87M, a decrease of -75.58%. That is a compound annual growth rate of -28.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 453.87M | -36.04% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |